Jul 27, 2020 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Kodiak Sciences Third Quarter R&D Webinar. My name is Keith, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions) Thank you. At this time, I'd like to turn the conference over to John Borgeson, CFO of Kodiak. Please go ahead.
John A. Borgeson - Kodiak Sciences Inc. - Senior VP, CFO & Secretary
Thank you for joining Kodiak Sciences Third Quarter R&D Webinar. I'm John Borgeson, Kodiak's Chief Financial Officer. Joining me today are Victor Perlroth, Chairman and CEO; and Jason Ehrlich, Chief Medical Officer and Chief Development Officer.
After our presentation discussing recent data from our ongoing Phase Ib study of KSI-301 and highlighting continued progress with our KSI-301 pivotal program, we will open the call for analyst Q&A.
Webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so
Kodiak Sciences Inc R&D Webinar Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers